PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer exosome 'micro factories' aid in cancer progression

Tiny nano-sized particles may play a major role in detecting and tracking breast cancer

Cancer exosome 'micro factories' aid in cancer progression
2014-10-23
(Press-News.org) Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University of Texas MD Anderson Cancer Center suggests Dicer may also serve as a biomarker for breast cancer and possibly open up new avenues for diagnosis and treatment. Results from the investigation were published in today's issue of Cancer Cell.

"Exosomes derived from cells and blood serum of patients with breast cancer, have been shown to initiate tumor growth in non-tumor-forming cells when Dicer and other proteins associated with the development of miRNAs are present," said Raghu Kalluri, M.D., Ph.D., chair of the department of cancer biology at MD Anderson. "These findings offer opportunities for the development of exosomes-based biomarkers and shed insight into the mechanisms of how cancer spreads."

Exosomes are small vesicles consisting of DNA, RNA and proteins enclosed in a membranes made up of two lipid layers. They perform specialized functions such as coagulation, intercellular signaling and cell "waste management." They are shed into bodily fluids forming a source of disease-specific nucleic acids and proteins. Increasingly, exosomes are studied for their potential as both indicators of disease, and as a prospective new treatment approach.

All exosomes contain a cellular stew of smaller components including proteins, messenger RNA (mRNA) and miRNAs. Kalluri's team reported that breast cancer associated exosomes contain specific miRNAs associated with a multi-protein complex known as RNA-induced silencing complex (RISC).

In addition to RISC, the breast cancer exosomes also house Dicer and two other proteins, AGO2 and TRBP, all of which together provoke tumor growth.

"The role of miRNAs associated with exosomes in cancer progression is largely unknown. Many studies have suggested the presence of miRNAs in exosomes and speculated on their function," said Kalluri. "We demonstrated that inhibiting the action of Dicer in cancer exosomes significantly impairs tumor growth, raising the possibility that miRNAs in exosomes contributes to cancer progression."

Kalluri's study indicated that the interplay between Dicer and its "host" exosome may allow cancer cells to develop an "oncogenic field effect" by manipulating surrounding cells via exosomes. Think of a child blowing a dying dandelion's spores into the wind where they float over a newly mowed lawn and one can envision how this molecular mixer easily spreads the disease to surrounding tissue.

"These studies reflect the need to evaluate the functional contribution of miRNA machinery in exosomes and their role in tumor progression and metastasis," said Kalluri.

INFORMATION:

Kalluri's MD Anderson team members included Sonia Melo and Hikaru Sugimoto, both postdoctoral fellows in cancer biology; Anthony Lucci , M.D., professor of surgical oncology; Cristina Ivan, gynecologic oncology; and George Calin, M.D., Ph.D., professor of experimental therapeutics. Other collaborating institutions included Beth Israel Deaconess Medical Center and Harvard Medical School in Boston; Bellvitge Biomedical Research Institute, Barcelona, Spain; The Netherlands Cancer Institute, Amsterdam, The Netherlands; and the Centre for Neuroscience and Cell Biology, Coimbra, Portugal.

The study was funded primarily by the Cancer Prevention and Research Institute of Texas. The authors are also supported by the National Science Foundation (EFRI-1240410, CBET-0922876 and CBET-1144025), the National Institutes of Health/National Cancer Institute (R01 EB003472, R01 EB006462, 1UH2TR00943-01, 1R01 CA182905-01, CA-163191, CA155370, CA 151925, DK 081576, and DK 055001), The National Cancer Institute (the Human Frontiers Science Program, the Alan M. Gewirtz Leukemia & Lymphoma Society, the MD Anders Research Trust, The University of Texas System Regents Health Research Scholarship program, and the CCL Global Research Foundation.


[Attachments] See images for this press release:
Cancer exosome 'micro factories' aid in cancer progression

ELSE PRESS RELEASES FROM THIS DATE:

TCGA study improves understanding of genetic drivers of thyroid cancer

2014-10-23
A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development. The findings also may help improve diagnosis and treatment. Investigators with The Cancer Genome Atlas (TCGA) Research Network identified new molecular subtypes that will help clinicians determine which tumors are more aggressive and which are more likely to respond to certain treatments. Their ...

Helping sweet cherries survive the long haul

2014-10-23
SUMMERLAND, BRITISH COLUMBIA - A new study says that cherry producers need to understand new intricacies of the production-harvest-marketing continuum in order to successfully move sweet cherries from growers to end consumers. For example, the Canadian sweet cherry industry has had to modify logistics strategies--from shorter truck or air shipping to long-distance containerized shipping--to accommodate burgeoning export markets. Keeping cherries fresh and consumer-ready during long ocean crossings challenges producers to find new ways to retain fruit quality for weeks. ...

Study finds significant increase in type 1 diabetes rates among non-Hispanic white youth

Study finds significant increase in type 1 diabetes rates among non-Hispanic white youth
2014-10-23
PASADENA, Calif., October 23, 2014 — The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes. The study included data from more than 2 million children and adolescents living in diverse geographic regions of the United States. Within this population, researchers identified 5,842 non-Hispanic white youth, 19 years old and younger, newly diagnosed with type 1 diabetes over the 8-year study period. They ...

Study: Some online shoppers pay more than others

2014-10-23
Internet users regularly receive all kinds of personalized content, from Google search results to product recommendations on Amazon. This is thanks to the complex algorithms that produce results based on users' profiles and past activity. It's Big Data at work, and it's often advantageous for users. But such personalization can also be a disadvantage to buyers, according to a team of Northeastern University researchers, when e-commerce websites manipulate search results or customize prices without the user's knowledge—and which in some cases leads to some online shoppers ...

Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma

2014-10-23
Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, reported St. Jude Children's Research Hospital scientists. The study will appear in the November 6 edition of the scientific journal Cell Reports. The treatment paired two chemotherapy drugs currently used to treat Ewing sarcoma (EWS) with experimental drugs called poly-ADP ribose polymerase (PARP) inhibitors that interfere with DNA repair. PARP inhibitors are currently ...

62 percent of colorectal cancer patients report financial burden from treatment, study finds

2014-10-23
ANN ARBOR, Mich. — Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy and among younger patients who worked in low-paying jobs. The study surveyed 956 patients who had been treated for stage 3 colorectal cancer. Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following ...

NASA's Terra satellite shows a more organized Tropical Storm Ana

NASAs Terra satellite shows a more organized Tropical Storm Ana
2014-10-23
The strong southwesterly wind shear that has been battering Tropical Storm Ana has abated and has given the storm a chance to re-organize. Ana appeared more rounded on imagery from NASA's Terra satellite as thunderstorms again circled the low-level center. NASA's Terra satellite passed over Ana on Oct. 22 at 22:10 UTC (6:10 p.m. EDT). The MODIS instrument aboard Terra captured a visible image of the storm that showed clouds and showers were no longer being blown northeast of the center from southwesterly wind shear, as they had in the last couple of days. The wind shear ...

Changes at the grocery store could turn the burden of shopping with children on its head

2014-10-23
Avoiding power struggles in the grocery store with children begging for sweets, chips and other junk foods – and parents often giving in – could be helped by placing the healthier options at the eye level of children and moving the unhealthy ones out of the way. A new study by researchers at the Johns Hopkins Bloomberg School of Public Health found that this dynamic is particularly frustrating for caregivers on limited budgets who are trying to save money and make healthy meals. The study, part of a project designed to encourage healthy food purchasing ...

Wayne State researcher finds key signaling pathway in cause of preeclampsia

2014-10-23
A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause of maternal and infant death worldwide, a discovery that could lead to the development of new therapeutic treatments. Nihar Nayak, D.V.M., Ph.D., is the principal investigator of the study, "Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications," published Oct. 20 in the online version of The Journal of Clinical Investigation. ...

Bradley Hospital finds sleep difficulties common among toddlers with psychiatric disorders

2014-10-23
PROVIDENCE, R.I. – John Boekamp, Ph.D., clinical director of the Pediatric Partial Hospital Program (PPHP) at Bradley Hospital recently led a study that found sleep difficulties - particularly problems with falling asleep - were very common among toddlers and preschool-aged children who were receiving clinical treatment for a wide range of psychiatric disorders. The study, titled "Sleep Onset and Night Waking Insomnias in Preschoolers with Psychiatric Disorders," is now published online in the journal Child Psychiatry & Human Development. "The most common sleep ...

LAST 30 PRESS RELEASES:

Atomic nucleus excited with laser: a breakthrough after decades

Losing keys and everyday items ‘not always sign of poor memory’

People with opioid use disorder less likely to receive palliative care at end of life

New Durham University study reveals mystery of decaying exoplanet orbits

The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed

Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses

Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

[Press-News.org] Cancer exosome 'micro factories' aid in cancer progression
Tiny nano-sized particles may play a major role in detecting and tracking breast cancer